Cargando…
End-of-life targeted degradation of DAF-2 insulin/IGF-1 receptor promotes longevity free from growth-related pathologies
Preferably, lifespan-extending therapies should work when applied late in life without causing undesired pathologies. Reducing insulin/insulin-like growth factor (IGF)-1 signaling (IIS) increases lifespan across species, but the effects of reduced IIS interventions in extreme geriatric ages remains...
Autores principales: | Venz, Richard, Pekec, Tina, Katic, Iskra, Ciosk, Rafal, Ewald, Collin Yvès |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492056/ https://www.ncbi.nlm.nih.gov/pubmed/34505574 http://dx.doi.org/10.7554/eLife.71335 |
Ejemplares similares
-
Sulforaphane promotes C. elegans longevity and healthspan via DAF-16/DAF-2 insulin/IGF-1 signaling
por: Qi, Zhimin, et al.
Publicado: (2021) -
CRISPR/Cas9 Genome Editing in Caenorhabditis elegans: Evaluation of Templates for Homology-Mediated Repair and Knock-Ins by Homology-Independent DNA Repair
por: Katic, Iskra, et al.
Publicado: (2015) -
Dauer-independent insulin/IGF-1-signalling implicates collagen remodelling in longevity
por: Ewald, Collin Y., et al.
Publicado: (2014) -
NADPH oxidase-mediated redox signaling promotes oxidative stress resistance and longevity through memo-1 in C. elegans
por: Ewald, Collin Yvès, et al.
Publicado: (2017) -
RNA surveillance via nonsense-mediated mRNA decay is crucial for longevity in daf-2/insulin/IGF-1 mutant C. elegans
por: Son, Heehwa G., et al.
Publicado: (2017)